2bPrecise Enterprise Platform
Point-of-care precision medicine platform integrated within any EHR
Platform · On PremiseCompany source
Company profile
About 2bPrecise
AI-powered precision medicine platform for personalized treatment recommendations and genomic analysis.
Company description 2bPrecise official website
Primary marketPrecision Medicine & Genomics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at 2bPrecise?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- cancer
- common conditions requiring medication management
- heritable genetic disorders
- inherited heart disease
- seizures
- syncope
Who it serves
- Health Systems
- Healthcare Enterprises
Deployment & integration
On Premise deployment with recorded integration context.
Recorded integration context: EHR systems (specific vendors not mentioned).
Geographic context
MarketsUnited States
Company sourceOfficial website
Company milestones
Platform expansion
Spartanburg Regional Healthcare System (SRHS) deployed 2bPrecise Enterprise (June 2025); Neurogen Biomarking partnership announced (May 2025); DPYD Safety Update released (October 2025)
Partnerships
Recorded partners
- Aranscia
- Neurogen Biomarking
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Family History & Pedigree Visualization
Genetics-focused data gathering and risk assessment tools
Software · On PremiseCompany source
Germline Testing Integration
Heritable factor analysis for diagnostic support
Software · On PremiseCompany source
Pharmacogenomics Module
Drug-gene interaction insights at the point of care
Software · On PremiseCompany source
Precision Oncology Module
Tumor profile integration and somatic results within EHR
Software · On PremiseCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
No linked records are currently available.
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Elimination of trial-and-error prescribing
Pharmacogenomics implementation
Accelerated patient response
Drug-gene interaction insights
Improved oncology workflows and efficiency
Tumor profile integration
Earlier disease stage intervention
Germline testing for diagnostic dilemmas
Spartanburg Regional Healthcare System (SRHS)
Enterprise-wide deployment of 2bPrecise platform
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from 2bPrecise
Recent articles published on 2bPrecise's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Precision Medicine & Genomics
Companies using AI to analyze genomic, proteomic, metabolomic, or multi-omics data to provide personalized treatment recommendations, identify genetic risks, or develop targeted therapies. Includes genomic sequencing platforms with AI analysis, preventive medicine based on genetic risk assessment, and longevity care based on molecular and genetic data.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.